Annual Current Assets
$102.77 M
-$87.82 M-46.08%
31 December 2023
Summary:
Adverum Biotechnologies annual total current assets is currently $102.77 million, with the most recent change of -$87.82 million (-46.08%) on 31 December 2023. During the last 3 years, it has fallen by -$331.67 million (-76.34%). ADVM annual current assets is now -76.34% below its all-time high of $434.44 million, reached on 31 December 2020.ADVM Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$161.08 M
-$18.34 M-10.22%
30 September 2024
Summary:
Adverum Biotechnologies quarterly total current assets is currently $161.08 million, with the most recent change of -$18.34 million (-10.22%) on 30 September 2024. Over the past year, it has increased by +$36.48 million (+29.28%). ADVM quarterly current assets is now -64.96% below its all-time high of $459.70 million, reached on 30 September 2020.ADVM Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADVM Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -46.1% | +29.3% |
| 3 y3 years | -76.3% | -53.7% |
| 5 y5 years | -50.8% | -3.9% |
ADVM Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -76.3% | at low | -53.7% | +56.7% |
| 5 y | 5 years | -76.3% | at low | -65.0% | +56.7% |
| alltime | all time | -76.3% | >+9999.0% | -65.0% | >+9999.0% |
Adverum Biotechnologies Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $161.08 M(-10.2%) |
| June 2024 | - | $179.42 M(-9.9%) |
| Mar 2024 | - | $199.13 M(+93.8%) |
| Dec 2023 | $70.24 M(-40.4%) | $102.77 M(-17.5%) |
| Sept 2023 | - | $124.60 M(-15.3%) |
| June 2023 | - | $147.14 M(-12.9%) |
| Mar 2023 | - | $168.87 M(-11.4%) |
| Dec 2022 | $117.78 M(-3.9%) | $190.59 M(-10.6%) |
| Sept 2022 | - | $213.24 M(-13.3%) |
| June 2022 | - | $246.03 M(-12.2%) |
| Mar 2022 | - | $280.12 M(-11.7%) |
| Dec 2021 | $122.58 M(+154.7%) | $317.14 M(-8.8%) |
| Sept 2021 | - | $347.83 M(-10.0%) |
| June 2021 | - | $386.27 M(-5.8%) |
| Mar 2021 | - | $409.86 M(-5.7%) |
| Dec 2020 | $48.13 M(+2.7%) | $434.44 M(-5.5%) |
| Sept 2020 | - | $459.70 M(+62.6%) |
| June 2020 | - | $282.68 M(-5.9%) |
| Mar 2020 | - | $300.45 M(+70.8%) |
| Dec 2019 | $46.86 M | $175.87 M(+4.9%) |
| Sept 2019 | - | $167.60 M(-7.2%) |
| June 2019 | - | $180.56 M(-6.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $193.14 M(-7.5%) |
| Dec 2018 | $4.74 M(-41.9%) | $208.75 M(-6.0%) |
| Sept 2018 | - | $222.17 M(-6.6%) |
| June 2018 | - | $237.92 M(-4.5%) |
| Mar 2018 | - | $249.20 M(+28.6%) |
| Dec 2017 | $8.16 M(-12.3%) | $193.74 M(+2.2%) |
| Sept 2017 | - | $189.52 M(-5.1%) |
| June 2017 | - | $199.64 M(-6.1%) |
| Mar 2017 | - | $212.64 M(-5.6%) |
| Dec 2016 | $9.31 M(+179.8%) | $225.27 M(-4.5%) |
| Sept 2016 | - | $235.90 M(-3.2%) |
| June 2016 | - | $243.57 M(-2.3%) |
| Mar 2016 | - | $249.23 M(-4.5%) |
| Dec 2015 | $3.33 M(+104.4%) | $260.99 M(-3.5%) |
| Sept 2015 | - | $270.36 M(-3.7%) |
| June 2015 | - | $280.63 M(-3.6%) |
| Mar 2015 | - | $291.13 M(+81.6%) |
| Dec 2014 | $1.63 M(+519.0%) | $160.28 M(-3.6%) |
| Sept 2014 | - | $166.33 M(+214.4%) |
| June 2014 | - | $52.90 M(+3.2%) |
| Mar 2014 | - | $51.27 M(+6136.7%) |
| Dec 2013 | $263.00 K(+6475.0%) | $822.00 K |
| Dec 2012 | $4000.00 | - |
FAQ
- What is Adverum Biotechnologies annual total current assets?
- What is the all time high annual current assets for Adverum Biotechnologies?
- What is Adverum Biotechnologies annual current assets year-on-year change?
- What is Adverum Biotechnologies quarterly total current assets?
- What is the all time high quarterly current assets for Adverum Biotechnologies?
- What is Adverum Biotechnologies quarterly current assets year-on-year change?
What is Adverum Biotechnologies annual total current assets?
The current annual current assets of ADVM is $102.77 M
What is the all time high annual current assets for Adverum Biotechnologies?
Adverum Biotechnologies all-time high annual total current assets is $434.44 M
What is Adverum Biotechnologies annual current assets year-on-year change?
Over the past year, ADVM annual total current assets has changed by -$87.82 M (-46.08%)
What is Adverum Biotechnologies quarterly total current assets?
The current quarterly current assets of ADVM is $161.08 M
What is the all time high quarterly current assets for Adverum Biotechnologies?
Adverum Biotechnologies all-time high quarterly total current assets is $459.70 M
What is Adverum Biotechnologies quarterly current assets year-on-year change?
Over the past year, ADVM quarterly total current assets has changed by +$36.48 M (+29.28%)